Evidence map›Paper›PMID 20586614›Full record

ArticleJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research2010

Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response.

Asen Bagashev, Michael C Fitzgerald, David F Larosa, Patrick P Rose, Sara Cherry, Alfred C Johnson, Kathleen E Sullivan

Open access · greenAbstract read
In one paragraph

Article in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. mSphere · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.International review of cell and molecular biology · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Human endogenous retroviruses and the nervous system.Handbook of clinical neurology · 2014
    Review
  12. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2013
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Asen BagashevThe Division of Allergy Immunology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Michael C Fitzgerald
David F Larosa
Patrick P Rose
Sara Cherry
Alfred C Johnson
Kathleen E Sullivan
National Institutes of Health · USUniversity of Pennsylvania · US

Funding

Immune Function and Biodefense in Immunocrompromised PopulationsN01AI50024 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI SULLIVAN, KATHLEEN · 2007 to 2011
$9.1M
TNF Alpha In InflammationR01AI044127 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI SULLIVAN, KATHLEEN E · 2000 to 2008
$2.6M
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050024N01AI050024 · NIAID · THE CHILDRENS HOSPITAL OF PHI · PI SULLIVAN, KATHLEEN · 2006 to 2006
–
NIAID NIH HHS N01AI50024NIAID NIH HHS R01AI44127
6 · The paper itself

Abstract

The cell autonomous response to viral infection is carefully regulated to induce type I interferons (IFNs), which in turn induce the establishment of an antiviral state. Leucine-rich repeat (in Flightless I) interacting protein-1 (LRRFIP1) and LRRFIP2 are 2 related proteins that have been identified as interacting with MyD88 and Flightless I homolog, a leucine-rich repeat protein. LRRFIP2 positively regulates NFκB and macrophage cytokine production after lipopolysaccharide, but less is known about LRRFIP1. We hypothesized that LRRFIP1 could be more important in antiviral responses, as overexpression led to type I IFN production in a pilot study. The induction of type I IFNs occurred even in the absence of virus, but was enhanced by the presence of virus. Conversely, knockdown of LRRFIP1 compromised IFN expression. We found that LRRFIP1 was rapidly recruited to influenza-containing early endosomes in a p38-dependent fashion. This was specific for virus-containing endosomes as there was almost no colocalization of LRRFIP1 with early endosomes in the absence of virus. Further, LRRFIP1 was recruited to RNA-containing vesicles. Taken together, these data suggest that LRRFIP1 participates in cell responses to virus at early time points and is important for type I IFN induction.

Indexed as

AnimalsEndosomesInfluenza A virusInterferon Type IMiceMyeloid Differentiation Factor 88NF-kappa BNIH 3T3 CellsOrthomyxoviridae InfectionsPhosphoproteinsProtein BindingProtein TransportRNA-Binding ProteinsRNA, Small InterferingTranscriptional ActivationTransgenesInterferon Type ILrrfip1 protein, mouseMyeloid Differentiation Factor 88NF-kappa BPhosphoproteinsRNA-Binding ProteinsRNA, Small Interfering

Identifiers

PMID20586614
PMCPMC2992405
OpenAlexW2020941901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.